Innovative immunological approaches aimed at modifying immune response will continue to play a significant role in the future of biomedical, medicine, biotechnology, and the pharmaceutical industries. This course will examine newer techniques and applications in the immunology field as they pertain to medical diagnostics and biotechnology. It will cover current principles and theories being developed, antibody structure and function, innate and adaptive immunity, cells involved in the immune response, complement, antigen-antibody reactions, and antibody detection for the diagnosis of infectious disease.
Course Number: BIOL-40043
Credit: 3.00 unit(s)
+ Expand All
-
1/6/2020 - 3/9/2020
$675
Online
-
-
-
CLASS TYPE:
Online, Web-based instruction
INSTRUCTOR:
Braciak, Todd, Assistant Member, Laboratory of Molecular Immunology and the Division of Immune Regulation, Torrey Pines Institute for Molecular Studies
Todd Braciak is an assistant member in the Laboratory of Molecular Immunology and the Division of Immune Regulation at the Torrey Pines Institute for Molecular Studies. He has over 18 years of research experience in immunology. He has been involved in applying gene therapy using recombinant adenovirus vectors for the treatment of cancer, autoimmune and infectious diseases.
-
-
POLICIES:
No refunds after: 1/13/2020.
-
1/6/2020 - 3/9/2020
ucsdextension.blackboard.com
You will have access to your course materials on the published start date OR 1 business day after your enrollment is confirmed if you enroll on or after the published start date.
-
3/30/2020 - 6/1/2020
$675
Online
-
-
-
CLASS TYPE:
Online, Web-based instruction
INSTRUCTOR:
Braciak, Todd, Assistant Member, Laboratory of Molecular Immunology and the Division of Immune Regulation, Torrey Pines Institute for Molecular Studies
Todd Braciak is an assistant member in the Laboratory of Molecular Immunology and the Division of Immune Regulation at the Torrey Pines Institute for Molecular Studies. He has over 18 years of research experience in immunology. He has been involved in applying gene therapy using recombinant adenovirus vectors for the treatment of cancer, autoimmune and infectious diseases.
-
TEXTBOOKS:
No information available at this time.
-
POLICIES:
No refunds after: 4/6/2020.
-
3/30/2020 - 6/1/2020
ucsdextension.blackboard.com
You will have access to your course materials on the published start date OR 1 business day after your enrollment is confirmed if you enroll on or after the published start date.
There are no sections of this course currently scheduled. Please contact the Science & Technology department at 858-534-3229 or unex-sciencetech@ucsd.edu for information about when this course will be offered again.